University of Calgary: Clinical Trials

912 trials sponsored by University of Calgary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

399 completed, 191 unknown, 118 recruiting, 71 not yet recruiting. 502 Not applicable, 118 Phase 2, 75 Phase 3, 48 Phase 1, 44 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable502Completed 255, Unknown 101, Recruiting 56, Not yet recruiting 31, Active not recruiting 24, Terminated 16, Withdrawn 11, Enrolling by invitation 6, Suspended 2
Phase 2118Completed 37, Unknown 33, Not yet recruiting 13, Recruiting 13, Terminated 13, Active not recruiting 5, Withdrawn 3, Enrolling by invitation 1
Phase 375Completed 31, Unknown 18, Recruiting 10, Terminated 10, Not yet recruiting 3, Active not recruiting 2, Withdrawn 1
Phase 148Completed 18, Not yet recruiting 10, Recruiting 6, Terminated 4, Unknown 4, Active not recruiting 3, Withdrawn 2, Suspended 1
Phase 444Completed 19, Terminated 8, Unknown 7, Not yet recruiting 4, Recruiting 3, Active not recruiting 2, Withdrawn 1
Early Phase 112Unknown 4, Completed 3, Active not recruiting 2, Not yet recruiting 2, Withdrawn 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Prevalence of Hyperglycemia in Surgical Patients With Pre-diabetes
Prediabetes or Diabetes, Surgery Complications
Not yet recruitingUniversity of Calgary7502027-05-012026-06-23
Heart tEam Decision-making Assisted by Revaz AI Trial
Revaz AI - Coronary Artery Disease
Not applicableNot yet recruitingUniversity of Calgary7122027-04-012026-09-24
PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot)
subcutaneous Teriparatide injection - Lower Extremity Fractures, Pelvis
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary542027-03-152026-10-06
Continuous vs Bolus Neuromuscular Blockade Regimens in Moderate to Severe Hypoxemic Respiratory Failure and ARDS (COBRA)
Neuromuscular Blocking Agent - Bolus Dosing, Neuromuscular Blocking Agent - Continuous Infusion - ARDS (Acute Respiratory Distress Syndrome)
Phase 2Not yet recruitingUniversity of Calgary1002027-01-012026-05-14
Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness
Synbiotic, Standard of Care (SOC) - Critical Illness
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary642027-01-012026-09-10
Clinical Performance of ComBaticâ„¢ Antimicrobial Wound Care Products in Hard-to-Heal Wounds
Irrigation Solution for wounds, Hydrogel for wound care - Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer), Chronic Wound Care
Phase 2Not yet recruitingUniversity of Calgary962027-01-012026-10-14
PAUSE: Sick Day Medication Management Mobile App Study
PAUSE App - Chronic Condition, Adverse Event
Not applicableNot yet recruitingUniversity of Alberta3202027-01-012026-06-25
Low-intensity Ultrasound for Individuals With Obsessive-compulsive Disorder
Low-intensity focused ultrasound (Active), Low-intensity focused ultrasound (Sham) - Obsessive Compulsive Disorder (OCD)
Not applicableNot yet recruitingUniversity of Calgary202026-11-012026-10-14
Lemborexant for Cannabis Use Disorder
Lemborexant 10mg, Placebo, Brief Behavioural Intervention - Cannabis Use Disorder
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary282026-11-012026-09-22
Spinal Cord Stimulation for Blood Pressure Control in Hypertension
Lower Thoracic Spinal Cord Stimulation - Hypertension (HTN)
Not applicableNot yet recruitingUniversity of Calgary112026-11-012026-09-25
SIMBA in Irritable Bowel Syndrome (IBS)
Rifaximin (drug), fluid biopsy capsule - Irritable Bowel Syndrome (IBS), Microbiome
Phase 1Not yet recruitingUniversity of Calgary1802026-11-012026-10-20
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
PEX010 25 mg psilocybin, PEX010 5 mg psilocybin, Standard Psilocybin-Assisted Therapy - Advanced Cancer, Demoralization
Phase 2Not yet recruitingUniversity of Calgary602026-10-302026-09-02
Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
Active Remote Electrical Neuromodulation, Sham Remote Electrical Neuromodulation - Migraine, Migraine Headache
Not applicableNot yet recruitingUniversity of Calgary302026-10-012026-08-19
National Surveillance and Prevention of Neonatal VAP
Ventilator-Associated Pneumonia (VAP), Neonatal, Bronchopulmonary Dysplasia (BPD)
Not yet recruitingUniversity of Alberta15002026-10-012026-06-25
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
Psilocybin - Post Traumatic Stress Disorder PTSD, Intimate Partner Violence (IPV)
Phase 2Not yet recruitingUniversity of Calgary762026-10-012026-09-08
Continuous Interscalene Blocks and Rebound Pain
Continuous interscalene nerve block, Interscalene Block - Total Shoulder Arthroplasty, Reverse Total Shoulder Arthroplasty
Not applicableNot yet recruitingUniversity of Calgary1542026-10-012026-08-19
Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism
sauna session - Primary Aldosteronism, Hypertension
Not applicableNot yet recruitingUniversity of Calgary102026-09-302026-08-31
Feasibility of Imaging Breast Implants With a Transmission-based Microwave Scanner
WVI-MIS-03-2025 - Breast - Female
Not applicableNot yet recruitingUniversity of Calgary102026-09-152026-06-25
Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients
Vernakalant, Amiodarone - Atrial Fibrillation, Post-cardiac Surgery
Phase 3Not yet recruitingUniversity of Calgary502026-09-012026-06-03
aVNT in POTS - Pilot
active aVNT vs. Sham - Postural Orthostatic Tachycardia Syndrome (POTS)
Not applicableNot yet recruitingUniversity of Calgary302026-09-012026-05-01

Showing 20 of 912. Sign in to see all of them.

Conditions studied

Motor Activity (42)  ·  Stroke (38)  ·  Depression (31)  ·  Anxiety Disorders (24)  ·  Neoplasms (22)  ·  Obesity (18)  ·  Depressive Disorder, Major (17)  ·  Ischemic Stroke (16)  ·  Renal Insufficiency, Chronic (16)  ·  Brain Concussion (15)  ·  Diabetes Mellitus (15)  ·  Heart Failure (15)  ·  Premature Birth (15)  ·  Asthma (12)  ·  Atrial Fibrillation (12)

Interventions

Exercise (16)  ·  Sodium Chloride (13)  ·  Transcranial Magnetic Stimulation (13)  ·  Standard of Care (12)  ·  Saline Solution (10)  ·  Cycloserine (9)  ·  Cognitive Behavioral Therapy (8)  ·  Lidocaine (8)  ·  Psilocybin (6)  ·  Transcranial Direct Current Stimulation (6)  ·  Aspirin (5)  ·  Fecal Microbiota Transplantation (5)  ·  Motivational Interviewing (5)  ·  Ondansetron (5)  ·  Sugars (5)

Countries

Canada (800)  ·  United States (43)  ·  Australia (14)  ·  United Kingdom (10)  ·  Switzerland (9)  ·  France (6)  ·  Ireland (6)  ·  Uganda (6)  ·  Denmark (5)  ·  Germany (5)  ·  Netherlands (5)  ·  Sweden (4)  ·  Belgium (3)  ·  Finland (3)  ·  Italy (3)

Top investigators

Satish R Raj, MD MSCI (10)  ·  Nicole Culos-Reed, PhD (9)  ·  Derek V Exner, MD, MPH (7)  ·  Lianne Tomfohr-Madsen, PhD (7)  ·  Raylene A Reimer, PhD, RD (7)  ·  Alexander McGirr, MD PhD (5)  ·  Maitreyi Raman, MD (5)  ·  Amanda Newton, PhD (4)  ·  Chad Bousman, PhD (4)  ·  Kerry A McBrien, MD, MPH (4)  ·  Konrad E Bloch, MD (4)  ·  Nauzer Forbes, MD MSc (4)  ·  Satish R Raj, MD, MSCI (4)  ·  Stephen Freedman, MD (4)  ·  Tavis S Campbell, PhD (4)

Results publications

PMID 42612036, PMID 25536308, PMID 35314481, PMID 35986306, PMID 39436396, PMID 40277027, PMID 10732933, PMID 10743805, PMID 110688, PMID 11421972, PMID 11440640, PMID 11445675, PMID 11932474, PMID 11959764, PMID 12123405, PMID 12534853, PMID 12558718, PMID 12617727, PMID 12743963, PMID 14751658, PMID 14758472, PMID 15252092, PMID 15305188, PMID 15454805, PMID 15491256, PMID 15673354, PMID 16002493, PMID 16011702, PMID 16014595, PMID 16051812, PMID 16203906, PMID 16307931, PMID 16320005, PMID 16380589, PMID 16505458, PMID 16625202, PMID 16764880, PMID 16781217, PMID 16899840, PMID 17075810, PMID 17093997, PMID 17161082, PMID 17592101, PMID 17650692, PMID 17905796, PMID 17931979, PMID 18032538, PMID 18053373, PMID 18058085, PMID 18068035

NIH funding

U01NS054630 (2), U01NS074425 (2), 1DP3DK104386-01 (1), 2019 (1), R01AI165327 (1), R34HL138110 (1), U01NS052220 (1), U01NS107486 (1), U10EY017014 (1), UC4DK101108-01 (1)